Construction of a Questionnaire on Panic Disorder and Agoraphobia
NCT03885453 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2019-03-21
Summary
For the first time panic disorder and agoraphobia are included as separate disorders in the DSM-5. Thus, agoraphobia no longer represents a subcategory of panic disorder. To diagnose both of the disorders, questionnaires are the method of choice. However, there are no measuring instruments available free of charge in German-speaking countries. In order to improve this situation, the Witten Panic Disorder Questionnaire (WPF) and the Witten Agoraphobia Questionnaire (WAF) are constructed in accordance with the DSM-5 criteria. Both measuring instruments are included as a part of a ten instrument battery. WAF and WPF will be delivered to a patient sample of patients with panic disorder and/or agoraphobia as well as depressed patients (discriminant validity). Factor analyzes and item analyses will be conducted.
Conditions
- Panic Disorder
- Panic Disorder With Agoraphobia
- Agoraphobia
- Agoraphobia With Panic Attacks
- Depression
Sponsors & Collaborators
-
Ulrike Willutzki
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-31
- Primary Completion
- 2022-12-01
- Completion
- 2022-12-01
Countries
- Germany
Study Locations
More Related Trials
-
Comparison of Psychotherapy Programs to Treat Panic Disorder
NCT00353470 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Cognitive-behavior Therapy on Fear Responses to Body Symptoms in Patients With Panic Disorder
NCT04568109 ·Status: COMPLETED ·Phase: NA
-
Quetiapine in Specific Phobia
NCT00872716 ·Status: COMPLETED ·Phase: PHASE2
-
Survey of the Anxiety Associated With the COVID-19 Pandemic
NCT04331106 ·Status: UNKNOWN
-
Pain Processing in Anxiety and Depression
NCT00560196 ·Status: COMPLETED
-
Psychodynamic Therapy for Treating Panic Disorder
NCT00128388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Association Between Physical Sensations and Thinking Styles
NCT03233542 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Hypnotherapy for Agoraphobia
NCT03684577 ·Status: COMPLETED ·Phase: NA
-
Cognitive Behavior Psychotherapy in Panic Disorder
NCT01025908 ·Status: COMPLETED ·Phase: NA
-
Psychotherapy Outcome and Self-selection Effects in Panic Disorder
NCT01606592 ·Status: COMPLETED ·Phase: NA
-
Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia
NCT00129610 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Treatment Change in Panic Disorder and Agoraphobia
NCT03547180 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder
NCT00705380 ·Status: COMPLETED ·Phase: PHASE2
-
Neuroimaging of Pavlovian Fear Conditioning Processes in Patients With Pathological Anxiety
NCT03498599 ·Status: UNKNOWN ·Phase: NA
-
Pre-procedural Information Sheet Reduces Anxiety of Patients Before Urodynamic Studies
NCT02009553 ·Status: UNKNOWN
-
Physical Activity and Cognitive Behavioural Therapy in Panic Disorder
NCT01788800 ·Status: COMPLETED ·Phase: NA
-
Longterm Outcome of Inpatient Cognitive and Behavioral Therapies for Agoraphobia
NCT01446172 ·Status: COMPLETED
-
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
NCT00062517 ·Status: COMPLETED
-
Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders
NCT00102427 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mobile-assisted Case Management for Panic Disorder
NCT05832905 ·Status: COMPLETED
-
Cognitive Behavioral Therapy in Panic Disorder
NCT00772746 ·Status: COMPLETED
-
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ
NCT00088738 ·Status: COMPLETED ·Phase: PHASE1
-
Scaling-up Psychological Interventions With Syrian Refugees in Switzerland
NCT03830008 ·Status: COMPLETED ·Phase: NA
-
COVID-19 and the Developement of Phobic Fears of Disease
NCT04359121 ·Status: UNKNOWN
-
A Brief Version of Biofeedback Therapy for Panic Disorder
NCT02826096 ·Status: COMPLETED ·Phase: NA